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Abstract
Mild cognitive impairment in Parkinson's disease (PD) is heterogeneous in regard to affected
domains. Although patterns of cognitive performance that may predict later dementia are as yet
undetermined, posterior-versus frontal-type assessments show promise for differential predictive
value. The present study included 70 individuals: 42 with idiopathic PD without dementia and 28
age- and education-matched healthy control adults (HC). Participants completed assessments of
cognition with emphasis on tests that are sensitive to frontal and posterior deficits. PD patients
were classified into cognitive subgroups and the subgroups were compared on demographic and
disease variables. Individual performance across neuropsychological tests was evaluated for the
PD group. Patients with PD performed more poorly than HC on several measures of cognition,
and they were classified into frontal (12), posterior (3), both (10) and neither subgroups (17), the
latter two in reference to frontal- and posterior-type deficits. The neither subgroup was
distinguished by less motor impairment than the both subgroup, but the four subgroups did not
otherwise differ on demographic or disease variables. Across patients, the tests most sensitive to
cognitive impairment included measures of attention and executive functioning (frontal-type
tests). Examination of individual test performance for PD revealed substantial heterogeneity
across tests with respect to number and severity of deficits. The current study provides insight into
which commonly used neuropsychological tests are most sensitive to cognitive deficits (strictly
defined) in a nondemented, well characterized PD sample, and into the relation of cognitive
subgroups to demographic and disease-specific variables.
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Cognitive impairment significantly impacts daily functioning and quality of life for many
individuals with Parkinson's disease (PD), and its accurate description is currently a topic of
great interest (Aarsland, Bronnick, & Fladby, 2011; Dalrymple–Alford et al., 2011;
Dalrymple–Alford et al., 2010; Litvan et al., 2012; Martinez–Horta & Kulisevsky, 2011).
Particular cognitive domains have been explored to greater and lesser extents in regard to
their impairment in PD. There is a long history of research revealing frontally based deficits
(Baddeley & Della Sala, 1996), whereas more recent studies have highlighted impairments
in visuospatial functions supported by the parietal lobes (Amick, Schendan, Ganis, &
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Cronin–Golomb, 2006; Cronin–Golomb, 2010; Davidsdottir, Wagenaar, Young, & Cronin–
Golomb, 2008; Schendan, Amick, & Cronin–Golomb, 2009). Visual and verbal long-term
memory, which rely in part on the temporal lobes, have also been noted to be affected in PD
(Amick, Grace, & Chou, 2006; Ibarretxe–Bilbao, Junque, Marti, & Tolosa, 2011). In a shift
from earlier literature, it has been suggested that cognitive dysfunction reflecting posterior
(parietal-temporal) brain dysfunction, rather than frontal dysfunction, is predictive of later
PD dementia (Williams–Gray et al., 2009; Williams–Gray, Foltynie, Brayne, Robbins, &
Barker, 2007).
Imaging studies indicate possible frontal and posterior cortical subtypes of PD, with some
evidence of posterior areas becoming more important in later stages of the disease (Paschali
et al., 2010). Frontostriatal deficits have been related to decreased dopamine levels, whereas
posterior-cortical deficits have been correlated with degeneration of cholinergic fibers
(Pagonabarraga & Kulisevsky, 2012). Reductions in cortical gray matter in posterior
temporal and parietal regions have also been reported in PD, and have been correlated with
visuospatial performance (Pereira et al., 2009). In a single-photon emission tomography
study, nondemented PD patients, and to a much greater extent PD patients with dementia,
exhibited decreased perfusion in parietal regions, leading the researchers to propose that this
sign may be an early marker of PD dementia (Firbank, Colloby, Burn, McKeith, & O'Brien,
2003).
Williams–Gray and colleagues suggested that there are distinct profiles of PD based on type
of cognitive deficit (Williams–Gray et al., 2009; Williams–Gray et al., 2007). These
investigators showed that frontostriatal deficits, as described by performance on a phonemic
verbal fluency task and the Tower of London test of executive dysfunction, were the most
common type of cognitive impairment among PD individuals without dementia. After 5
years, deficits in performance on a test of semantic verbal fluency and on copying a drawing
of intersecting pentagons, both reflecting what they described as posterior cortex
dysfunction, were significantly predictive of dementia, whereas frontostriatal deficits were
not (Williams–Gray et al., 2009). These authors cautioned against relying too heavily on a
binary description of these subtypes of tests, because many commonly used tasks rely on
networks of multiple brain regions. Williams–Gray and colleagues used a cut-off criterion of
one standard deviation (SD) below normative data for most tests and did not directly
compare their PD group to a control group.
A methodological issue in examining cognitive status in PD is the definition of the cut-off
score that serves as the criterion for a deficit. An analysis of deficit cut-off scores by
Dalrymple–Alford and colleagues showed that 1.5 SD below the normative score on two or
more tests within a cognitive domain or on one test from each of two different domains were
best at identifying PD with mild cognitive impairment (MCI) and minimizing MCI
categorization for cognitively intact participants (Dalrymple–Alford et al., 2011). The
eventual goal of this line of research is to identify those PD patients at increased risk for
progressive cognitive decline and dementia, with the aim of implementing clinical
interventions at the earliest possible stage.
The Movement Disorders Society recently called upon investigators to focus on
comprehensive cognitive assessments and specific neuropsychological deficits in order to
elucidate the nature of cognitive dysfunction and decline in PD (Litvan et al., 2011; Litvan
et al., 2012). Dementia in PD is associated with increased disability and mortality and
reduced quality of life (Aarsland & Kurz, 2010), and the ability to plan ahead and to attempt
early intervention could greatly impact patient care. If neuropsychological patterns of
deficits in PD are indicative of prognosis for decline, this type of assessment could be used
early in the disease course to predict later cognitive decline.
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The present study examined nondemented PD and healthy control participants (HC) on a
larger number of tests of cognition than are usually administered, and that rely on frontal-
and posterior-type networks. The primary goal was to evaluate the nature of the frontal
versus posterior subtyping. We determined the degree of PD-related cognitive deficits on
these measures using a strict definition of impairment of performance relative to the
performance of HC, which is not regularly done in studies of PD cognition. The second goal
was to examine cognitive performance within individual PD participants. We hypothesized
that PD patients would perform more poorly than HC. In regard to categorization of patients
into cognitive-deficit subgroups based on performance of the frontal- and posterior-type
tests, we expected that more patients would exhibit frontal-type than posterior-type deficits,
as found by Williams–Gray and colleagues using a less strict criterion. Examining group and
individual neuropsychological profiles on frontal- and posterior-type measures may provide
further information about the PD participants who are classified into neuropsychological
deficit subgroups, with implications for tests that could be used to identify early cognitive
change.
Methods
Participants
There were 70 individuals in this study: 42 patients with idiopathic PD (21 women, 21 men)
and 28 age- and education-matched HC adults (14 women, 14 men; see Table 1). The study
protocol was approved by the Boston University Institutional Review Board, with consent
obtained according to the Declaration of Helsinki.
Patients with PD were referred from the Parkinson's Disease Center of Boston Medical
Center and local support groups, and included patients who met the clinical criteria for mild
to moderate PD: Hoehn and Yahr stages I-III (Hoehn & Yahr, 1967). Diagnoses were made
by patients' neurologists, using United Kingdom Parkinson's Disease Society Brain Bank
clinical diagnostic criteria (Hughes, Daniel, Kilford, & Lees, 1992). The HC were recruited
from the general community. Exclusion criteria included coexisting serious chronic illness
(including psychiatric or neurological), use of psychoactive medications besides
antidepressants and anxiolytics in the PD group, which are commonly prescribed; use of any
psychoactive medication in the HC group; history of intracranial surgery, traumatic brain
injury, alcoholism or other drug abuse; and visual acuity poorer than 20/40. Participants
were not demented as indicated by scores on the modified form on the Mini-Mental State
Examination (mMMSE; Stern, Sano, Paulson, & Mayeux, 1987), as described in previous
studies (Appleman, Stavitsky, & Cronin–Golomb, 2011; Seichepine et al., 2011). Motor
disability was rated with the Unified Parkinson's Disease Rating Scale (UPDRS; Fahn &
Elton, 1987), using a total score calculated from the motor section (sum of items 18–44).
Psychomotor speed was assessed with the Purdue Pegboard test (Purdue, 1948), using the
average number of pegs placed bilaterally.
The majority of patients reported using dopamine agonists (N = 29, 69%) and/or levodopa
(N = 26, 62%). Twenty-six (62%) used monamine oxidase inhibitors and/or catechol-O-
methyltransferase inhibitors and 9 (21%) used amantadine and/or anticholinergic agents.
Eleven (26%) reported using antidepressant or antianxiety medications. Levodopa
equivalent dosages (LED) were calculated based on previous reports with LED (Gjerstad,
Boeve, Wentzel–Larsen, Aarsland, & Larsen, 2008). All patients were tested in their “on”
medication state.
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Measures and Procedures
Participants completed a detailed cognitive assessment as described below. We compared
performance between PD and HC, and we examined within-individual test performance on
variables from all assessments administered. Because there were differences in the
proportion of men to women across groups and because some studies find gender
differences on cognitive tasks (Miller & Cronin–Golomb, 2010), within-group gender
comparisons were conducted. No gender differences were found for either group, and
accordingly the data were combined for group analyses. The PD patients were categorized
into cognitive deficit subgroups based on performance on a selection of the frontal-type and
posterior-type measures that identified the greatest percentage of deficit among the PD
patients. Definition of frontal- and posterior-type measures was consistent with that of
Williams–Gray and colleagues, with posterior tests defined as those implicating areas and
networks posterior to the frontal lobes. Raw scores, total correct, were used unless otherwise
indicated.
Cognitive Assessment
Five frontal-type and six posterior-type tests were administered. Tests that have been shown
to rely on frontal or posterior regions either in lesion studies or imaging studies were
selected (Ibarretxe–Bilbao et al., 2011; Lezak, Howieson, Loring, Hannay, & Fischer, 2004).
Frontal-Type Tests
The Stroop Color–Word task (Stroop, 1935; executive functioning)—Participants
named the colors of xxxx's (Stroop Color), read color words (in black ink; Stroop Word), and
named the color of ink in which incongruent ink/color words were written (Stroop Color–
Word), each as quickly as possible.
The Delis–Kaplan Executive Functioning Systems (D-KEFS) Verbal Fluency
task (Delis, Kaplan, & Kramer, 2001)—Phonemic and Switching verbal fluency):
Participants named as many words beginning with the letters F, A, and S and as many
alternating fruits and pieces of furniture as possible, each in 1-min trials.
The Digit Span subtest from the Wechsler Memory Scale III (Wechsler, 1997;
attention [Forward and Backward conditions] and working memory [Backward
condition])—Participants first repeated and then reversed verbally presented digit
sequences.
The Trail Making Test (Tombaugh, 2004; attention, set-shifting, and executive
function)—Participants quickly drew lines connecting numbers in order for Condition A
(attention). For Condition B, participants quickly drew lines alternating between numbers
and letters in order (set-shifting, executive function). Completion time for Trails A and
Trails B were used for analysis.
The Ruff Figural Fluency Test (Ruff, Light, & Evans, 1987; nonverbal fluency)
—Participants connected dots to draw unique designs in five trials of 60 s each. Number of
total unique designs was used for analysis.
Posterior-Type Tests
The Cube and Pentagon Copying tasks from the mMMSE (visuospatial and
visuomotor abilities)—Participants copied a three-dimensional cube and two overlapping
pentagons. Scoring systems previously applied to PD by Maeshima and colleagues (cube)
(Maeshima, Itakura, Nakagawa, Nakai, & Komai, 1997; Maeshima et al., 2004) and
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Jefferson and colleagues (pentagon; Jefferson et al., 2002) were used to obtain a total score
for each.
The D-KEFS Verbal Fluency task (Delis et al., 2001; semantic fluency)—
Participants named as many animals as possible in 1 min.
The Landmark Line Bisection task (Davidsdottir et al., 2008; Lee, Harris,
Atkinson, & Fowler, 2001; spatial perception without motor demands)—
Participants viewed a computerized horizontal line crossed by a moving vertical mark, and
indicated when the mark reached the perceived center of the line. The average of the
absolute value of 10 trials was used for analysis.
Visual Dependence task (Azulay, Mesure, Amblard, & Pouget, 2002; Danta &
Hilton, 1975; Davidsdottir et al., 2008; visual dependence without motor
demands)—Participants viewed a computerized rotating rod and indicated when the rod
reached horizontal. The average of 10 trials was used for analysis.
The Delayed condition from the Rey Auditory Verbal Learning Test (RAVLT)
(Rey, 1964; delayed memory)—Participants recalled as many words as possible from a
previously learned list after a 20-min delay.
Subtyping by Type of Cognitive Deficit
Means and SD were calculated for HC for frontal- and posterior-type tests. The PD scores
were compared to these scores, and any PD whose score fell 1.5 SD below the HC mean was
considered to have a deficit on that task. Five variables from each category (frontal-,
posterior-type) that identified the greatest percentage of cognitive deficit in PD were used
for subtyping. Patients with deficits on two or more frontal-type tasks were categorized as
having a frontal deficit. If they had deficits on two or more posterior-type tasks, they were
categorized as having a posterior deficit. Four groups were established: frontal deficit only,
posterior deficit only, frontal and posterior deficit (both), and neither.
Statistical Analyses
Independent groups t tests were performed to compare the effect of group (HC, PD) on
neuropsychological test performance. Because we examined a number of frontal- and
posterior-type tests, some of which were intercorrelated, a conservative alpha of .01 was
used to assess significance. Nonparametric statistics (Mann–Whitney U tests) were used for
comparisons when the sample size was small. As the data reflect the results of an ongoing
study on PD and cognition, some participants were not administered all tests.
Results
Comparison of HC and PD Cognition
The HC significantly outperformed PD on most variables (see Table 2), including both
conditions of the Trail Making Test, A: t(65) = 5.44, p < .001; B: t(60) = 4.56, p < .001, all
conditions of the Stroop Tests, Color: t(55) = 3.07, p < .01; Word: t(68) = 5.32, p < .001;
Color-Word: t(67) = 2.79, p < .01, Digit Span Backward, t(65) = 2.98, p < .01, Phonemic
Fluency, t(48) = 6.76, p < .001 Ruff Figural Fluency, t(66) = 3.03, p < .01, Line Bisection,
t(66) = 2.63, p < .01 and Visual Dependence, t(68) = 2.50, p < .01 (see Figure 1). There
were trends toward group differences with HC outperforming PD on Digit Span Forward,
t(65) = 1.62, p = .06, Cube Copy, t(67) = 1.6, p = .06, Switching Fluency, t(46) = 2.04, p = .
03 and RAVLT Delay, t(46) = 1.68, p = .05. Groups were not significantly different on
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Semantic Fluency, t(66) = 1.16, p = .13 or Pentagon Copy, t(54) = 0.48, p = .32. The HC
also significantly outperformed PD on bilateral performance of the Purdue Pegboard test, the
screening measure of psychomotor speed, t(68) = 5.31, p < .001.
Individual Performance Across Tests
Deficits at 1.5 SD below the HC mean were calculated for all PD for each test variable.
Table 2 lists the number and percentage of deficits in the PD group for all test variables
examined. Phonemic Fluency (52%) identified the most deficits for PD, and RAVLT Delay
(12%) showed the least. Figure 2 displays PD deficits across tests. The number and severity
of deficits based on z-scores is depicted for each individual. Number of deficits across all
test variables examined ranged from zero (two individuals) to 12 (two individuals). Severity
of deficit on all test variables ranged from no deficit to nearly 11 SD below the HC mean
(for one participant on Trail Making B).
Classification into Cognitive Subgroups
Each individual with PD was classified into the frontal, posterior, both, and neither cognitive
subgroups as described above, based on the five tests from each category that showed the
largest percentage of deficit for the PD group. Frontal-type tests included Phonemic
Fluency, Trail Making Test A, Stroop Word, Trail Making Test B, and Ruff Figural
Fluency. Posterior-type tests included Line Bisection, Cube Copy, Pentagon Copy, Visual
Dependence, and Semantic Fluency. This categorization described 12 individuals with
frontal deficit (scores 1.5 SD below the NC mean on two or more frontal tasks), three with
posterior deficit (scores 1.5 SD below the NC mean on two or more posterior tasks), 10 both
(scores 1.5 SD below the NC mean on two or more frontal tasks and two or more posterior
tasks), and 17 neither (scores that did not meet criteria for a deficit subgroup: deficits that
did not meet the level (>1.5 SC below the NC mean, or number [two deficits within a
domain] criteria; Figure 2 and Table 3). Of those classified as neither, 12 exhibited deficits
at a subthreshold level: Nine had one frontal-test deficit, none had a posterior deficit, and
three had one deficit in each category.
We then compared the frontal, both, and neither deficit subgroups on demographic and
disease characteristics (see Table 3) of age, education, UPDRS motor score, disease
duration, and LED. The number of individuals in the posterior subgroup was too small for
statistical analysis. The neither subgroup had significantly lower (less impaired) UPDRS
motor scores (p < .01) than did the both subgroup, but otherwise did not differ on
demographic or disease-related variables. There were no significant differences between
frontal and both or between frontal and neither on any demographic or disease characteristic.
There were trends toward group differences between frontal and neither on education (p = .
031, neither higher educated than frontal) and UPDRS motor score (p = .046, frontal more
severe motor scores than neither), and between both and neither on education (p = .015,
neither higher educated than both) and LED (p = .056, both with higher medication doses
than neither).
Discussion
The nondemented PD patients in this study performed more poorly than HC on several
measures of cognition, and they fell into cognitive deficit-based groups. These results
supported our hypotheses that PD would perform more poorly than HC and that more
patients would exhibit frontal-type than posterior-type deficits. Our results are consistent
with the literature on cognitive performance in PD. We found that some tests (Trail Making,
Phonemic Fluency) were better at identifying specific deficits than others (Semantic
Fluency, RAVLT Delay). Examination of individual test performance for PD across all
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measures administered, not just those used for categorization, revealed substantial
heterogeneity in cognitive performance across tests with respect to number and severity of
deficits even within categorization groups (see Figure 2).
Using the five tests from each category that were most sensitive to deficits, we categorized
PD into subgroups based on type of deficit. We found that although a number of individuals
had a single (frontal) deficit, many other participants were categorized as both or neither and
only three participants were categorized as posterior alone. Because we did have a number
of individuals in the both deficit group and few in the posterior deficit group, it appears that
posterior-type deficits present after frontal-type deficits, or potentially that individuals in our
sample who had posterior-type deficits in the past, now had deficits in both domains at the
time of testing. Neither explanation is inconsistent with the findings of Williams–Gray and
colleagues of the prevalence of frontal-type deficits or their proposal that posterior-type
deficits may be indicative of future dementia (Williams–Gray et al., 2009).
Seventeen participants were categorized as neither, meaning that they did not meet the level
criterion (>1.5 SD below the NC mean) or number criterion (two deficits within a domain)
for deficit group membership. It is worth noting that only five of these 17 PD were free of
all cognitive deficits across the 10 variables used for categorization and only two were
completely deficit-free when all test variables were considered (see Figure 2). The
remaining individuals exhibited potential deficits on these measures at a subthreshold level.
Three of the 17 neither participants exhibited one deficit in each of the two domains (frontal-
and posterior-type tests); the categorization method required two deficits per domain for
inclusion in the category. Dalrymple–Alford et al. proposed that one deficit in each of two
domains is sufficient for MCI classification, though two deficits per domain is more robust
(Dalrymple–Alford et al., 2011). Longitudinal study is needed to know which of these
participants with potential subthreshold deficit will go on to develop functionally and
clinically significant cognitive dysfunction. Future studies should further examine
demographic and disease characteristics across cognitive deficit subgroups to determine if
there is a specific phenotype associated with type of cognitive deficit. It will be important to
follow the neither group longitudinally to see if and when individuals in this group develop
cognitive deficits. The existence of heterogeneous mild (subthreshold) deficits is consistent
with other studies of cognition in nondemented PD patients; this heterogeneity represents a
continuing challenge in the literature on classifying cognitive impairment in PD (Jellinger,
2012; Martinez–Horta & Kulisevsky, 2011).
Some of the tests in our study had a motor component. To address the possible relation
between motor symptom severity and cognitive performance, we correlated UPDRS motor
scores with performance on each of the cognitive tests that included a motor component. For
the PD group as a whole, there were significant correlations between the UPDRS motor
score and Trail Making Test A and Trail Making Test B (p's <.01), though not between the
UPDRS motor score and other measures with a motor component (Ruff Figural Fluency,
Cube Copy, Pentagon Copy). We also examined the correlations for each of the
categorization groups and found no significant correlations between motor severity score
and any cognitive variables. Additionally, we correlated each of the cognitive tests with
scores on the Purdue Pegboard, a test of psychomotor speed, which we administered to all of
our participants. There were no significant correlations between Purdue Pegboard scores and
any cognitive measure with a motor component for the PD group as a whole or when each
categorization group was examined separately. The results of these analyses suggest that
motor symptom severity is in part, but not wholly, related to cognitive performance on some
tests involving motor response. Parkinson's disease affects multiple systems including
networks supporting motor and cognitive functions, so this complicated relation is
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representative of the disease process and does not appear to differentiate individuals in our
categorization groups.
The cognitive deficit subgroup results were different from those found by Williams–Gray
and colleagues (Williams–Gray et al., 2009; Williams–Gray et al., 2007), who used
longitudinal clinical and cognitive data to estimate contributors to dementia status. Our
study differed in four principal ways: It was a cross-sectional examination of cognitive
performance; our analyses focused on performance on a larger number of frontal- and
posterior-type neuropsychological tests; we used a stricter definition of deficit (1.5 SD
below the mean rather than 1.0 SD criterion); and we compared PD to control performance
as well as examining performance within the PD group. Williams–Gray and colleagues
found that semantic fluency and pentagon copy were most predictive of future dementia, but
those tests did not differentiate PD from HC in our study and were not the most sensitive
tests in our assessment. It may be that even subtle deficits on these measures predict later
decline. Alternatively, differences in results could be due to true heterogeneity in PD
cognitive performance across our samples. Our entire sample was nondemented, whereas the
sample from Williams–Gray and colleagues was an incident cohort followed over time. We
also defined deficit more strictly, as noted above.
Though our sample size was not large, we nevertheless found highly significant group
differences between patients and an age- and education-matched control group, as have
other studies with samples of this size (e.g., Burn et al., 2006; Seichepine et al., 2011). We
also saw a pattern of subgroups based on performance deficits emerge from our sample. An
advantage of our study over others is that we used a neuropsychological assessment
addressing multiple frontal- and posterior-type skills commonly impacted by PD, and we
were able to consider differences in multiple disease and demographic characteristics in
relation to the cognitive deficit subtypes.
We used an age- and education-matched healthy control group for this study, and all
participants (PD, HC) were from the greater Boston area. We used this method rather than
using published norms in order to mitigate possible group differences based on these
demographic variables. Our goal was to focus on the variables from each test that
highlighted the greatest percentage of deficit for PD patients. Because normative data for
many neuropsychological tests are not consistent in accounting for demographic variables
such as education, we consider our method to be more reliable in identifying participants
with mild deficits. Had we used normative data for each of the various tests, deficits that are
very real to our well-educated PD patients may have been masked by comparison with a less
well-matched control group. Although impairment in our PD patients may have been
overemphasized as compared with the general population, our method and results may be
useful in determining cognitive decline for PD patients with these demographic
characteristics in future longitudinal studies.
The Movement Disorders Society (MDS) Task Force recently listed guidelines for
characterizing PD-MCI (Litvan et al., 2012), including recommendations for the types of
assessments that should be used for diagnosis. The task force suggested that multiple
cognitive domains should be assessed with multiple neuropsychological measures, and that
MCI diagnosis should require the presence of deficits on at least two tests within a cognitive
domain. The task force highlighted the importance of additional research into the number
and type of neuropsychological tests most appropriate for diagnosing MCI in PD. In
accordance with these MCI guidelines, future studies using larger neuropsychological
assessments should continue to examine test performance both within and across
participants. In the current study, although the only statistically significantly difference
between subgroups was the UPDRS motor score between the both and neither subgroups,
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several other demographic variables showed a trend toward group differences. The impact of
demographic and disease characteristics such as age, education, duration of disease, and
severity of the disease should be formally examined in larger studies of frontal-versus
posterior-subgroups, as these variables may provide appropriate characterization of
subgroup membership. As previously discussed, several functional imaging studies have
also implicated frontal and posterior subtypes of PD. If functional imaging studies show
patterns that are analogous to behaviorally based neuropsychological patterns of deficits in
PD, and frontal- and posterior-type deficit subgroups continue to be supported as
meaningful, the combination of noninvasive imaging and detailed neuropsychological
assessment could be useful in identifying early cognitive impairment as well as predicting
the course of cognitive decline over time.
The current study provides insight into which of the commonly used neuropsychological
tests should be used to highlight PD-specific cognitive deficits, as well as into the extent of
heterogeneity in cognitive performance in nondemented individuals with PD. The number of
cognitive tests needed for frontal versus posterior classification should be a direction of
future research. Additional cross-sectional and longitudinal studies examining frontal and
posterior subgroups while implementing the MDS Task Force guidelines will help to answer
some of the remaining questions about what constitutes MCI in PD. Our results with
neuropsychologically determined PD subgroups may inform future definitions of this
construct.
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Figure 1.
PD performance across neuropsychological tests, as compared with HC performance (HC z-
scores = 0).
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Figure 2.
Cognitive Performance for Individual PD Participants. TrA: Trail Making A completion
time; TrB: Trail Making B completion time; StC: Stroop Color; StW: Stroop Word; StCW:
Stroop Color-Word; DSF: Digit Span – Forward; DSB: Digit Span Backward; PhF:
Phonemic Fluency; SwF: Switching Fluency; Ruff: Ruff Figural Fluency; Cube: Cube Copy;
Pent: Pentagon Copy; SeF: Semantic Fluency; VsD: Visual Dependence; LnB: Line
Bisection; RvD: RAVLT Delay.
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Table 1
Participant Characteristics
PD participants (N = 42) HC participants (N = 28)
Age 64.8 (7.7) 63.9 (8.6)
Education 17.3 (2.1) 17.3 (1.8)
Male: female 21:21 14:14
UPDRS motor score 20.1 (9.1) NA
PD duration 6.7 (4.1) NA
Hoehn & Yahr median (range) 2.0 (1–3) NA
LED 356.5 (246.0) NA
Note. LED = Levodopa equivalent dosage; HC = healthy controls; PD = Parkinson's disease; UPDRS = Unified Parkinson's Disease Rating Scale.
All values are mean (SD) unless noted.
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Table 2
Comparison of HC and PD Cognitive Performance
Test name PD (#) HC (#) PD, mean (SD) HC, mean (SD)
PD-HC
significant
difference (1-
tailed p-value)
# of PD with
deficits
% of PD
with deficits
Frontal-type tests
 Phonemic Fluency 42 28 39.6 (8.1) 55.4 (10.4) <.001 22 52%
 Trails A time (sec) 42 28 34.3 (9.8) 24.5 (5.1) <.001 21 50%
 Stroop Word 42 28 87.5 (13.4) 106.4 (16.2) <.001 18 43%
 Trails B time (sec) 42 28 86.8 (41.2) 54.1 (17.6) <.001 15 36%
 Ruff Unique Designs 40 28 79.2 (20.0) 93.9 (19.0) <.01 11 28%
 Switching Fluency 25 23 12.7 (3.1) 14.5 (3.0) <.05 7 28%
 Stroop Color-Word 41 28 34.2 (10.6) 41.0 (9.2) <.01 10 24%
 Stroop Color 42 28 62.1 (11.5) 71.1 (12.4) <.01 7 17%
 Digit Span Backward 41 26 7.6 (2.5) 9.7 (3.1) <.01 6 15%
 Digit Span Forward 41 26 10.8 (2.4) 11.8 (2.3) .06 6 15%
Posterior-type tests
 Line Bisection 42 28 1.3 (.62) 1.0 (.34) <.01 14 33%
 mMMSE Cube Copy 42 27 6.0 (1.3) 6.5 (.94) .06 13 31%
 mMMSE Pentagon Copy 31 25 6.9 (.89) 7.0 (.68) .32 9 30%
 Visual Dependence 42 28 .53 (.46) .29 (.25) <.01 10 24%
 Semantic Fluency 40 28 21.8 (5.7) 23.5 (6.0) .13 4 13%
 RAVLT Delay 25 23 8.2 (3.3) 9.9 (3.6) .05 3 12%
Note. mMMSE = Modified Mini-Mental State Examination; RAVLT Delay = Rey Auditory Verbal Learning Test, Delayed Condition; Visual
Dependence = mean deviation from horizontal (/10 trials); Line Bisection = absolute mean % deviation from center of line (/10 trials). Test
variables are listed in descending order based on percentage of PD deficit. Mean (SD) total score unless indicated otherwise.
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Table 3
Comparison of Deficit Groups
Frontal (N = 12) Posterior (N = 3) Both (N = 10) Neither (N = 17)
Age 65.2 (7.6) 63.7 (8.5) 68.0 (8.4) 62.8 (7.3)
Education 16.7 (1.4) 19.7 (1.5) 15.8 (2.2) 18.2 (1.9)
Male: Female 6:6 2:1 5:5 8:9
PD duration 6.0 (2.7) 5.0 (2.0) 8.1 (4.0) 6.6 (5.1)
H&Y median (range) 2 (1.5–2.5) 1.5 (1–3) 2 (1.5–3) 2 (1–3)
UPDRS motor 21.2 (8.5) 19.7 (10.3) 27.8 (9.5)* 15.0 (5.8)
LED 471.3 (301.1) 226.1 (35.5) 515.5 (189.3) 285.0 (205.8)
Note. H&Y = Hoehn and Yahr staging; UPDRS = Unified Parkinson's Disease Rating Scale; LED = Levodopa equivalent dosage.
*Significant difference between both and neither, p < .01.
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